Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis
- 1 November 2007
- journal article
- polycythemia vera
- Published by Elsevier in Experimental Hematology
- Vol. 35 (11), 1657-1667
- https://doi.org/10.1016/j.exphem.2007.08.021
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A developmental view of microRNA functionTrends in Biochemical Sciences, 2007
- Dynamic regulation of miRNA expression in ordered stages of cellular developmentGenes & Development, 2007
- CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation controlProceedings of the National Academy of Sciences, 2007
- JAK-2 mutations and their relevance to myeloproliferative diseaseCurrent Opinion in Hematology, 2007
- Polycythemia vera is not initiated by JAK2 mutationExperimental Hematology, 2007
- JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersCancer, 2006
- The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia veraBlood, 2006
- The Role of JAK2 V617F Mutation, Spontaneous Erythropoiesis and Megakaryocytopoiesis, Hypersensitive Platelets, Activated Leukocytes, and Endothelial Cells in the Etiology of Thrombotic Manifestations in Polycythemia Vera and Essential ThrombocythemiaSeminars in Thrombosis and Hemostasis, 2006
- MicroRNA fingerprints during human megakaryocytopoiesisProceedings of the National Academy of Sciences, 2006
- MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulationProceedings of the National Academy of Sciences, 2005